Medicus Pharma (STU:N460) ROCE % : -221.48% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Medicus Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medicus Pharma's annualized ROCE % for the quarter that ended in Sep. 2024 was -221.48%.

Medicus Pharma ROCE % Historical Data

The historical data trend for Medicus Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma ROCE % Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial							-	-519.16	-2,928.57	-504.87	-221.48

Medicus Pharma ROCE % Calculation

Medicus Pharma's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-5.543	/	( ( (0.267 - 11.782)	+	(1.736 - 0.997) )	/ 2 )
	=	-5.543	/	( (-11.515	+	0.739)	/ 2 )
	=	-5.543	/	-5.388
	=	102.88 %

Medicus Pharma's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-10.632	/	( ( (8.158 - 1.917)	+	(5.155 - 1.795) )	/ 2 )
	=	-10.632	/	( ( 6.241	+	3.36 )	/ 2 )
	=	-10.632	/	4.8005
	=	-221.48 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Medicus Pharma (STU:N460) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medicus Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (STU:N460) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

MDCX:USA N460:Germany MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.medicuspharma.com

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

Medicus Pharma Headlines

No Headlines